Global, regional, and national burdens of acute respiratory infections among children and adolescents from 1990 to 2021: A systematic analysis

Abstract

Objective: To evaluate the global, regional, and national burden and determinants of Acute Respiratory Infections (ARIs) among children and adolescents from 1990 to 2021.

Methods: We analysed ARI mortality and disability-adjusted life years (DALYs), stratified by age, sex, and economic development level based on data retrieved from the Global Burden of Disease study 2021. Decomposition and frontier analyses were employed to identify key drivers of burden variation and visualize potential reductions based on development levels.

Results: Between 1990 and 2021, the global burden of ARIs showed a significant decline in both achievable age-standardized DALYs rate and age-standardized mortality rates (EAPC= –3.87 and –3.81, respectively). Different age groups and sex witnessed different levels of ARI burden, males experienced heavier burden than females and the 0-4 years-old group experienced heavier burden than other study age groups. Most of the 204 countries and territories experienced a downward trend of ARI burden, with slight increases observed only in Lesotho and Dominica. A negative correlation was found between the Socio-demographic Index and ARI burden. Decomposition analysis indicated that the significant decreases in deaths and DALYs were primarily driven by epidemiological changes.

Conclusions: The global burden of ARIs among children and adolescents has declined over the past three decades, but substantial regional disparities persist. Targeted public health strategies are needed to address the continued ARI burden in high-risk regions and vulnerable age groups.

Keywords

Respiratory infection / Global disease burden / Decomposition analysis / Frontier analysis

Conflict of interest statement

The authors declare no conflicts of interest related to this study. All authors have contributed to the research and writing of this manuscript, and the results are presented in an impartial manner. No financial or personal relationships could influence the work presented in this manuscript.

Funding

The authors received no extramural funding for this study.

Authors' contributions

Y.Z. and D.Z. conceived and supervised the study and reviewed the manuscript critically for important intellectual content. X.M. and S.L. participated in the study design, collected the data, performed the data analysis, and drafted the manuscript. M.L., X.C. and H.X. organized the tables. The author(s) read and approved the final manuscript.

Publisher’s note

The Publisher of the Journal remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Edited by Lei Y, Zhang Q, Pan Y

References

[1] World Health Organization. Global Health Estimates 2016: Deaths bycause, age, sex, by country and by region. [Online]. Available from: http://www.who.int/healthinfo/global_burden_disease/estimates/en/index1.html. [Accessed on 31 December 2025].

[2] Zhang L, Wang Y, Xu H, Hao L, Zhao B, Ye C, et al. Prevalence of respiratory viruses in children with acute respiratory infections in Shanghai, China, From 2013 to 2022. Influenza Other Respir Viruses 2024; 18(5): e13310.

[3] Li Z, Zhang H, Ren L, Lu Q, Ren X, Zhang C, et al. Etiological and epidemiological features of acute respiratory infections in China. Nat Commun 2021; 12(1): 5026.

[4] Li Y, Wang X, Blau DM, Caballero MT, Feikin DR, Gill CJ, et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: A systematic analysis. Lancet 2022; 399(10340): 20472064.

[5] Ryu S, Cowling BJ. Human influenza epidemiology. Cold Spring Harb Perspect Med 2021; 11(12): a038356.

[6] Howard LM, Edwards KM, Zhu Y, Williams DJ, Self WH, Jain S, et al. Parainfluenza virus types 1-3 infections among children and adults hospitalized with community-acquired pneumonia. Clin infect Dis 2021; 73(11): e4433-e4443.

[7] Chen C, You Y, Du Y, Zhou W, Jiang D, Cao K, et al. Global epidemiological trends in the incidence and deaths of acute respiratory infections from 1990 to 2021. Heliyon 2024; 10(16): e35841.

[8] Graham NMH. The epidemiology of acute respiratory infections in children and adults: A global perspective. Epidemiol Rev 1990; 12(1): 149178.

[9] Williams BG, Gouws E, Boschi-Pinto C, Bryce J, Dye C. Estimates of world-wide distribution of child deaths from acute respiratory infections. Lancet infect Dis 2002; 2(1): 25-32.

[10] Viner RM, Coffey C, Mathers C, Bloem P, Costello A, Santelli J, et al. 50-year mortality trends in children and young people: A study of 50 low-income, middle-income, and high-income countries. Lancet 2011; 377(9772): 1162-1174.

[11] Ward JL, Azzopardi PS, Francis KL, Santelli JS, Skirbekk V, Sawyer SM, et al. Global, regional, and national mortality among young people aged 10-24 years, 1950-2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet 2021; 398(10311): 1593-1618.

[12] Ferrari AJ, Santomauro DF, Aali A, Abate YH, Abbafati C, Abbastabar H, et al. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: A systematic analysis for the Global Burden of Disease Study 2021. Lancet 2024; 403(10440): 21332161.

[13] Du Y, Yan R, Wu X, Zhang X, Chen C, Jiang D, et al. Global burden and trends of respiratory syncytial virus infection across different age groups from 1990 to 2019: A systematic analysis of the Global Burden of Disease 2019 study. Int J Infect Dis 2023; 135: 70-76.

[14] Global Health Data Exchange. Global burden of disease study 2021. [Online]. Available from: https://ghdx.healthdata.org/gbd-2021. [Accessed on 31 December 2025].

[15] Hankey BF, Ries LA, Kosary CL, Feuer EJ, Merrill RM, Clegg LX, et al. Partitioning linear trends in age-adjusted rates. Cancer Causes Control 2000; 11(1): 31-35. doi: 10.1023/a:1008953201688.

[16] Lin Y, Fang K, Zheng Y, Wang H, Wu J. Global burden and trends of neglected tropical diseases from 1990 to 2019. J Travel Med 2022; 29(3): taac031.

[17] Chevan A, Sutherland M. Revisiting das gupta: Refinement and extension of standardization and decomposition. Demography 2009; 46(3): 429449.

[18] Gupta PD. A general method of decomposing a difference between two rates into several components. Demography 1978; 15(1): 99-112.

[19] Scharl T, Grün B, Leisch F. Mixtures of regression models for time course gene expression data: Evaluation of initialization and random effects. Bioinformatics 2010; 26(3): 370-377.

[20] Xie Y, Bowe B, Mokdad AH, Xian H, Yan Y, Li T, et al. Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016. Kidney Int 2018; 94(3): 567-581.

[21] Adkins B, Leclerc C, Marshall-Clarke S. Neonatal adaptive immunity comes of age. Nat Rev Immunol 2004; 4(7): 553-564.

[22] Simon AK, Hollander GA, McMichael A. Evolution of the immune system in humans from infancy to old age. Proc R Soc B 2015; 282(1821): 20143085.

[23] Levy O. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol 2007; 7(5): 379-390.

[24] Tregoning JS, Schwarze J. Respiratory viral infections in infants: Causes, clinical symptoms, virology, and immunology. Clin Microbiol Rev 2010; 23(1): 74-98.

[25] Troeger CE, Khalil IA, Blacker BF, Biehl MH, Albertson SB, Zimsen SRM, et al. Quantifying risks and interventions that have affected the burden of lower respiratory infections among children younger than 5 years: An analysis for the Global Burden of Disease Study 2017. Lancet Infect Dis 2020; 20(1): 60-79.

[26] Jackson S, Mathews KH, Pulani D, Falconer R, Rudan I, Campbell H, et al. Risk factors for severe acute lower respiratory infections in children: A systematic review and meta-analysis. Croat Med J 2013; 54(2): 110121.

[27] Kyu HH, Vongpradith A, Sirota SB, Novotney A, Troeger CE, Doxey MC, et al. Age-sex differences in the global burden of lower respiratory infections and risk factors, 1990-2019: Results from the Global Burden of Disease Study 2019. Lancet Infect Dis 2022; 22(11): 1626-1647.

[28] Kampmann B, Madhi SA, Munjal I, Simões EAF, Pahud BA, Llapur C, et al. Bivalent prefusion F vaccine in pregnancy to prevent RSV illness in infants. N Engl J Med 2023; 388(16): 1451-1464.

[29] Chen C, Ang G, Akksilp K, Koh J, Scott JAG, Clark A, et al. Reevaluating the impact and cost-effectiveness of pneumococcal conjugate vaccine introduction in 112 low-income and middle-income countries in children younger than 5 years: A modelling study. Lancet Glob Health 2024; 12(9): e1485-e1497.

[30] Presa J, Arranz-Herrero J, Alvarez-Losa L, Rius-Rocabert S, Pozuelo MJ, Lalueza A, et al. Influenza vaccine outcomes: A meta-analysis revealing morbidity benefits amid low infection prevention. Eur Respir Rev 2025; 34(175): 240144.